Search

Li X Zhao

from Mountain View, CA
Age ~64
Get Report
Also known as:
Lixin X Zhao, Lixin Hao
Related to:
Shunyu Zhao, 36Donna D Ha, 73Zhaoqing Lang, 62Zhaoxian Lang, 68Sheng Zhao, 34
Connected to:
Alicia E Zhao, 29Allan Zhao, 29Anni Zhao, 37April Zhao, 67Beiping Zhao, 39Betty Y Zhao, 55Bohan Zhao, 33Brandon A Zhao, 32Byron D Zhao, 57Can Zhao, 36

Li Zhao Phones & Addresses

  • Mountain View, CA
  • Santa Clara, CA
  • Cupertino, CA

Professional Records

License Records

Li Zhao

License #:
="25120" - Active
Issued Date:
Nov 17, 2006
Renew Date:
Dec 1, 2015
Expiration Date:
Nov 30, 2017
Type:
Certified Public Accountant

Resumes

Resumes

Li Zhao Photo 1

Li Zhao St. Louis, MO

View page
Work:
Department of Earth and Atmospheric Sciences
St. Louis, MO
Sep 2011 to Dec 2011
Instructor of Lab of Advanced Petrology
Saint Louis University
St. Louis, MO
Aug 2007 to Aug 2011
Research Assistant
Geological Museum of China

Jun 2006 to Oct 2006
China, Petrographic Data Entry
Lab of Petrology

Jun 2005 to Jun 2006
Instructor
Education:
China University of Geosciences
Jun 2006
Geology
Saint Louis University
St. Louis, MO
Doctor of Philosophy in Geophysics
School of Earth Sciences and Resources
Bachelor of Science in Geology
Skills:
Geochemical Data Analysis; Satellite Images Analysis; Field Work; ArcGIS; Microsoft; CorelDRAW
Li Zhao Photo 2

Li Zhao Sacramento, CA

View page
Work:
Bright Horizon Chinese School
Foster City, CA
Aug 2005 to Nov 2011
Teacher
Bright Horizon Chinese School
Foster City, CA
Aug 2005 to Nov 2011
Teacher
Shanghai Gaojing High School, Shanghai, China

Mar 1999 to Jun 2005
Teacher
Guyuan Teachers Training College

Sep 1996 to Jul 1998
Teacher
Education:
Shanghai International Studies University
Sep 1989 to Jul 1991
Bachelor of Literature
Skills:
Chinese language speaking, reading and writing / Typing in Chinese and English / Computer soft ware such as Word, Excel and power-pont / computer using skill such as e-mail and Internet searching.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Li Hua Zhao
President
MOSAIC VENTURE, INC
1321 Sydney Dr, Sunnyvale, CA 94087
Li Feng Zhao
President
APUSONE TECHNOLOGY US LIMITED
1413 Grant Rd, Mountain View, CA 94040

Publications

Isbn (Books And Publications)

Hong Kong Under Chinese Rule: The Economic and Political Implications of Reversion

View page
Author

Li Zhao

ISBN #

0521621585

Hong Kong Under Chinese Rule: The Economic and Political Implications of Reversion

View page
Author

Li Zhao

ISBN #

0521627613

Us Patents

Apo A-I Mimetic Peptides And Methods Of Treatment

View page
US Patent:
7985727, Jul 26, 2011
Filed:
Sep 20, 2007
Appl. No.:
11/858851
Inventors:
Katsuyuki Murase - Cupertino CA, US
Li Zhao - Mountain View CA, US
Irina Astafieva - Palo Alto CA, US
Paul M. Consigny - San Jose CA, US
Assignee:
Abbott Cardiovascular Systems Inc. - Santa Clara CA
International Classification:
A61K 38/10
A61K 31/661
US Classification:
514 2, 514 12, 514 13, 530300, 424 91
Abstract:
A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a synthetic apolipoprotein A-1 (Apo A-I) mimetic peptide into a wall of the blood vessel at the particular region, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including a synthetic apolipoprotein A-I (Apo A-I) mimetic peptide, or combination of an Apo A-I synthetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of an endogenous Apo A-I related peptide. A composition including an apolipoprotein A-1 (Apo A-I) synthetic peptide in a form suitable for delivery into a blood vessel, the peptide including an amino acid backbone that has less amino acid residues relative to endogenous Apo A-I and a chimera of helix 1 and helix 9 of Apo A-I.

Sustained Release Of Apo A-I Mimetic Peptides And Methods Of Treatment

View page
US Patent:
7985728, Jul 26, 2011
Filed:
Sep 20, 2007
Appl. No.:
11/858862
Inventors:
Katsuyuki Murase - Cupertino CA, US
Li Zhao - Mountain View CA, US
Irina Astafieva - Palo Alto CA, US
Paul M. Consigny - San Jose CA, US
Stephen D. Pacetti - San Jose CA, US
Dariush Davalian - San Jose CA, US
Syed Fayaiz Ahmed Hossainy - Fremont CA, US
Florian N. Ludwig - Mountain View CA, US
Jinping Wan - Mountain View CA, US
John Stankus - Campbell CA, US
Rachel Bright - Palo Alto CA, US
Assignee:
Abbott Cardiovascular Systems Inc. - Santa Clara CA
International Classification:
C07K 14/00
A61K 38/00
US Classification:
514 2, 530300
Abstract:
A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (Apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (Apo A-I) synthetic peptide, or combination of an Apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various Apo A-I mimetic peptides, or endogenous Apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous Apo A-I.

Sustained Release Of Apo A-I Mimetic Peptides And Methods Of Treatment

View page
US Patent:
8101565, Jan 24, 2012
Filed:
Nov 27, 2007
Appl. No.:
11/946026
Inventors:
Katsuyuki Murase - Cupertino CA, US
Syed F. A. Hossainy - Fremont CA, US
Irina Astafieva - Palo Alto CA, US
Li Zhao - Mountain View CA, US
Hong Ma - Cupertino CA, US
Assignee:
Abbott Cardiovascular Systems Inc. - Santa Clara CA
International Classification:
C07K 14/00
A61K 38/00
US Classification:
514 2, 530300
Abstract:
A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.

User Selectable Multiple Protocol Network Interface Device

View page
US Patent:
8340120, Dec 25, 2012
Filed:
Sep 30, 2009
Appl. No.:
12/570565
Inventors:
Venkata Pramod Balakavi - San Jose CA, US
Venky Nagapudi - Milpitas CA, US
Surya Prakash Varanasi - Dublin CA, US
Li Zhao - San Jose CA, US
Yash V. Bansal - Sunnyvale CA, US
Assignee:
Brocade Communications Systems, Inc. - San Jose CA
International Classification:
H04L 12/66
US Classification:
370463, 370401, 370466
Abstract:
An Ethernet/Fiber Channel network interface device which can be configured by a user to operate on an FC SAN, a CEE network or both. In one embodiment the configuration can be done using jumpers or connections to the pins of a chip, thus allowing a manufacturer to only inventory one device for use with either or both networks. In a second embodiment the configuration can be done in software by setting registers and memory values on the device. This embodiment allows the device to be changed between configurations without removing it from the server or blade. The devices according to the preferred embodiments further reduce power consumption by shutting down portions of the chip not needed based on the configuration of the device.

Apo A-I Mimetic Peptides And Methods Of Treatment

View page
US Patent:
8383592, Feb 26, 2013
Filed:
Jul 6, 2011
Appl. No.:
13/177473
Inventors:
Katsuyuki Murase - Cupertino CA, US
Li Zhao - Mountain View CA, US
Irina Astafieva - Palo Alto CA, US
Paul M. Consigny - San Jose CA, US
Assignee:
Abbott Cardiovascular Systems Inc. - Santa Clara CA
International Classification:
C07K 7/00
C07K 14/00
US Classification:
514 213
Abstract:
A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a synthetic apolipoprotein A-1 (Apo A-I) mimetic peptide into a wall of the blood vessel at the particular region, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including a synthetic apolipoprotein A-I (Apo A-I) mimetic peptide, or combination of an Apo A-I synthetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of an endogenous Apo A-I related peptide. A composition including an apolipoprotein A-1 (Apo A-I) synthetic peptide in a form suitable for delivery into a blood vessel, the peptide including an amino acid backbone that has less amino acid residues relative to endogenous Apo A-I and a chimera of helix 1 and helix 9 of Apo A-I.

Regional Delivery Of Therapeutic Agents For The Treatment Of Vascular Diseases

View page
US Patent:
20080146489, Jun 19, 2008
Filed:
Dec 15, 2006
Appl. No.:
11/639512
Inventors:
Stephen D. Pacetti - San Jose CA, US
Paul M. Consigny - San Jose CA, US
Ronald W. Heil - Roseville MN, US
Florian Niklas Ludwig - Mountain View CA, US
Dariush Davalian - San Jose CA, US
Li Zhao - Mountain View CA, US
Irina Astafieva - Palo Alto CA, US
Jinping Wan - San Jose CA, US
Katsuyuki Murase - Cupertino CA, US
Syed F.A. Hossainy - Fremont CA, US
Rachel Bright - Claremont CA, US
Jeffrey Ellis - San Francisco CA, US
International Classification:
A61F 2/06
A61K 31/27
A61K 31/44
A61K 31/56
A61K 31/66
A61K 38/02
A61P 9/00
US Classification:
514 2, 514102, 514177, 514336, 514478, 623 121
Abstract:
The present invention relates to the regional delivery of therapeutic agents for the treatment of vascular diseases wherein regional delivery refers to delivery of a therapeutically effective amount of the therapeutic agent to an area of the vessel that includes not only afflicted tissue but non-afflicted tissue at the periphery of the afflicted tissue as well.

Nanoparticle-Coated Medical Devices And Formulations For Treating Vascular Disease

View page
US Patent:
20090047318, Feb 19, 2009
Filed:
Aug 16, 2007
Appl. No.:
11/840119
Inventors:
Florian Niklas Ludwig - Mountain View CA, US
Syed Faiyaz Ahmed Hossainy - Fremont CA, US
Katsuyuki Murase - Cupertino CA, US
Li Zhao - Mountain View CA, US
Irina Astafieva - Palo Alto CA, US
Assignee:
Abbott Cardiovascular Systems Inc. - Santa Clara CA
International Classification:
A61F 13/00
A61K 31/56
A61K 36/13
A61K 38/00
A61K 9/127
A61K 9/50
US Classification:
424422, 424450, 424490, 424770, 514 11, 514 12, 514171, 514 2, 977907, 977931
Abstract:
Nanoparticle-coated medical devices, nanoparticle-containing formulations and methods of using for treating a vascular disease are disclosed.

Nanoparticle-Coated Medical Devices And Formulations For Treating Vascular Disease

View page
US Patent:
20100104506, Apr 29, 2010
Filed:
Jan 5, 2010
Appl. No.:
12/652668
Inventors:
Florian Niklas Ludwig - Zurich, CH
Syed Faiyaz Ahmed Hossainy - Hayward CA, US
Katsuyuki Murase - Cupertino CA, US
Li Zhao - Mountain View CA, US
Irina Astafieva - Palo Alto CA, US
Assignee:
Abbott Cardiovascular Systems Inc. - Santa Clara CA
International Classification:
A61K 51/00
A61K 9/00
A61K 31/56
A61K 31/4353
A61K 31/337
A61K 31/66
A61K 38/16
A61K 49/00
A61K 49/06
A61K 49/22
A61K 49/04
A61P 9/00
US Classification:
424 111, 424422, 514178, 514291, 514449, 514108, 514 12, 424 91, 424 93, 424 95, 424 94, 977773
Abstract:
Nanoparticle-coated medical devices, nanoparticle-containing formulations and methods of using for treating a vascular disease are disclosed. The medical device includes a coating that comprises a plurality of nanoparticles, wherein the nanoparticles comprise one or more bioactive agents encapsulated within, adhered to a surface of or integrated into the structure of the nanoparticles and further comprise one or more contrast enhancing agents encapsulated within, adhered to a surface of or integrated into the structure of the nanoparticles.
Control profile
Li X Zhao from Mountain View, CA, age ~64 Get Report